{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:37:17Z","timestamp":1777365437990,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ygyno.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T02:00:18Z","timestamp":1632362418000},"page":"517-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Patterns of care and outcomes of radiotherapy or hormone therapy in patients with medically inoperable endometrial adenocarcinoma"],"prefix":"10.1016","volume":"163","author":[{"given":"Leonid B.","family":"Reshko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy T.","family":"Gaskins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Rattani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa A.","family":"Farley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant W.","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.09.006_bb0005","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0010","series-title":"Uterine Neoplasms. NCCN Guidelines Version 1.2021","author":"Abu-Rustum","year":"2021"},{"key":"10.1016\/j.ygyno.2021.09.006_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/IGC.0000000000000609","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"26","author":"Colombo","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.09.006_bb0020","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.brachy.2017.01.011","article-title":"Management of elderly patients with early-stage medically inoperable endometrial cancer: systematic review and National Cancer Database analysis","volume":"16","author":"Dutta","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2021.09.006_bb0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.brachy.2015.06.002","article-title":"Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer","volume":"14","author":"Schwarz","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2021.09.006_bb0030","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0360-3016(93)90454-4","article-title":"Treatment of endometrial carcinoma with radiation therapy alone","volume":"27","author":"Kupelian","year":"1993","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2011.09.022","article-title":"Primary radiation therapy for medically inoperable patients with clinical stage I and II endometrial carcinoma","volume":"124","author":"Podzielinski","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5468\/ogs.2020.63.3.337","article-title":"Medically unfit women with early-stage endometrial cancer treated with the levonorgestrel intrauterine system","volume":"63","author":"Nikolopoulos","year":"2020","journal-title":"Obstet. Gynecol. Sci."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0045","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.3892\/ol.2016.4390","article-title":"Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment","volume":"11","author":"Macchia","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.brachy.2020.04.005","article-title":"COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation","volume":"19","author":"Williams","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2021.09.006_bb0055","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2020.06.486","article-title":"Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: international expert consensus recommendations","volume":"158","author":"Elledge","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2020.05.020","article-title":"Radiation and hormonal therapy for primary treatment of stage I endometrial cancer and long-term survival","volume":"158","author":"Pyrzak","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.08.007","article-title":"All-cause mortality in young women with endometrial cancer receiving progesterone therapy","volume":"217","author":"Ruiz","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.brachy.2014.12.003","article-title":"Primary radiotherapy for nonsurgically managed stage I endometrial cancer: utilization and impact of brachytherapy","volume":"14","author":"Gill","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2021.09.006_bb0075","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/COC.0000000000000204","article-title":"Definitive radiation therapy for stage I-II endometrial cancer: an observational study of nonoperative management","volume":"40","author":"Yoo","year":"2017","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0360-3016(96)00486-5","article-title":"Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy: results of 12 years of experience with 280 patients","volume":"37","author":"Knocke","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gore.2018.04.009","article-title":"Endometrial cancer in an increasingly obese population: exploring alternative options when surgery may not cut it","volume":"25","author":"Staples","year":"2018","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0090","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ijrobp.2005.04.036","article-title":"Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma","volume":"63","author":"Niazi","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/clon.1999.9059","article-title":"Primary radiotherapy for carcinoma of the endometrium using external beam radiotherapy and single line source brachytherapy","volume":"11","author":"Churn","year":"1999","journal-title":"Clin. Oncol. (R Coll Radiol.)"},{"key":"10.1016\/j.ygyno.2021.09.006_bb0100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.brachy.2014.07.002","article-title":"Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma","volume":"13","author":"Gill","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2021.09.006_bb0105","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/gyno.1998.5148","article-title":"High-dose-rate brachytherapy for medically inoperable stage I endometrial cancer","volume":"71","author":"Nguyen","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/gyno.1996.0123","article-title":"Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma with endometrium","volume":"61","author":"Fishman","year":"1996","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0115","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ijrobp.2007.10.026","article-title":"High-dose-rate Rotte \u201cY\u201d applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10-year results","volume":"71","author":"Coon","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0125","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mob.2002.122130","article-title":"Intrauterine progesterone treatment of early endometrial cancer","volume":"186","author":"Montz","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2011.11.043","article-title":"Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature","volume":"125","author":"Baker","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijrobp.2012.02.058","article-title":"Use of image-guided stereotactic body radiation therapy in lieu of intracavitary brachytherapy for the treatment of inoperable endometrial neoplasia","volume":"85","author":"Kemmerer","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0145","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1245\/s10434-016-5699-9","article-title":"Levonorgestrel-releasing intrauterine systems versus Oral cyclic medroxyprogesterone acetate in endometrial hyperplasia therapy: a meta-analysis","volume":"24","author":"Yuk","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0150","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jso.23568","article-title":"Comparing national cancer registries: the National Cancer Data Base (NCDB) and the surveillance, epidemiology, and end results (SEER) program","volume":"109","author":"Mohanty","year":"2014","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1158\/1055-9965.EPI-07-2567","article-title":"Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype","volume":"17","author":"McCullough","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2288-11-129","article-title":"Imputation of missing values of tumour stage in population-based cancer registration","volume":"11","author":"Eisemann","year":"2011","journal-title":"BMC Med. Res. Methodol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.09.006_bb0165","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0175","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the Levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0180","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijrobp.2020.09.016","article-title":"Current status of clinical trials for cervical and uterine cancer using immunotherapy combined with radiation","volume":"109","author":"Dyer","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2021.09.006_bb0185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jrr\/rry003","article-title":"Carbon-ion radiotherapy for inoperable endometrial carcinoma","volume":"59","author":"Irie","year":"2018","journal-title":"J. Radiat. Res."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821013755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821013755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:58:10Z","timestamp":1758772690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821013755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0090825821013755"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.09.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of care and outcomes of radiotherapy or hormone therapy in patients with medically inoperable endometrial adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}